KRISTIN C. PECK - 20 Feb 2024 Form 4 Insider Report for Zoetis Inc. (ZTS)

Role
Chief Executive Officer, Director
Signature
/s/ Brenda Santuccio, as Attorney-in-Fact
Issuer symbol
ZTS
Transactions as of
20 Feb 2024
Net transactions value
-$1,834,466
Form type
4
Filing time
21 Feb 2024, 16:39:26 UTC
Previous filing
13 Feb 2024
Next filing
01 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZTS Common Stock Options Exercise $599,170 +13,000 +16% $46.09 92,366 20 Feb 2024 Direct F1
transaction ZTS Common Stock Sale $2,433,636 -13,000 -14% $187.20 79,366 20 Feb 2024 Direct F2
holding ZTS Common Stock 794 20 Feb 2024 401(k) F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZTS Stock Option Options Exercise $0 -13,000 -4.6% $0.000000 270,014 20 Feb 2024 Common Stock 13,000 Direct F4, F5, F6, F7, F8
holding ZTS Stock Option 62,500 20 Feb 2024 Common Stock 62,500 $196.14 Direct F7, F9, F10
holding ZTS Stock Option 67,148 20 Feb 2024 Common Stock 67,148 $162.07 Direct F7, F9, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2023.
F2 The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.56 to $187.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Represents the common stock equivalents held in the Zoetis Inc. Savings Plan, a 401(k) plan, as of December 31, 2023.
F4 Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
F5 13,000 options granted February 27, 2015 at an exercise price of $46.09 per option.
F6 Each option vests on the third anniversary of the date of grant.
F7 Each option expires on the tenth anniversary of the date of grant.
F8 382 options granted February 27, 2015 at an exercise price of $46.09 per option; 20,000 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14,2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option; and 54,751 options granted February 8, 2022 at an exercise price of $201.30 per option.
F9 Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
F10 One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 6, 2024.
F11 One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 8, 2023.